-
1.CHIRAL SYNTHESIS OF PYRROLIDINE CORE COMPOUNDS EN ROUTE TO NEURONAL NITRIC OXIDE SYNTHASE INHIBITORS 审中-公开
标题翻译: 吡咯啉核心化合物在神经元型一氧化氮合酶抑制剂途径中的手性合成公开(公告)号:WO2012003427A3
公开(公告)日:2012-04-12
申请号:PCT/US2011042758
申请日:2011-07-01
发明人: SILVERMAN RICHARD B , XU FENGTIAN
IPC分类号: C07D401/06 , C07B55/00 , C07D401/14
CPC分类号: C07D401/06 , C07D401/12 , C07D493/08
摘要: A chiral synthesis of pyrrolidine compounds en route to seletive neuronal nitric oxide synthase inhibitors, and representative inhibitor compounds heretofore unattainable.
摘要翻译: 吡咯烷化合物的手性合成途径为选择性神经元型一氧化氮合酶抑制剂,以及迄今为止无法达到的代表性抑制剂化合物。
-
2.PYRIMIDINE-2,4,6-TRIONES FOR USE IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS 审中-公开
标题翻译: 用于治疗前列腺癌的吡嗪-2,4,6-TRIONES公开(公告)号:WO2010129665A3
公开(公告)日:2011-04-07
申请号:PCT/US2010033714
申请日:2010-05-05
申请人: CAMBRIA PHARMACEUTICALS INC , UNIV NORTHWESTERN , KIRSCH DONALD R , BENMOHAMED RADHIA , ARVANITES ANTHONY C , MORIMOTO RICHARD I , XIA GUOYAO , SILVERMAN RICHARD B
发明人: KIRSCH DONALD R , BENMOHAMED RADHIA , ARVANITES ANTHONY C , MORIMOTO RICHARD I , XIA GUOYAO , SILVERMAN RICHARD B
IPC分类号: C07D239/62 , A61K31/495 , A61P25/28 , C07D403/02
CPC分类号: C07D239/62 , C07D403/06 , C07D403/14 , C07D409/06 , C07D413/06
摘要: The present invention relates to the identification of inventive pyrimidine-2,4,6- triones (PYT compounds) and pharmaceutical compositions thereof for treating subjects with amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The invention also provides methods of preparing the inventive PYT compounds.
摘要翻译: 本发明涉及用于治疗肌萎缩性侧索硬化(ALS)和其它神经变性疾病的受试者的本发明的嘧啶-2,4,6-三雄(PYT化合物)及其药物组合物的鉴定。 本发明还提供了制备本发明的PYT化合物的方法。
-
3.AMINOPYRIDINE DIMER COMPOUNDS, COMPOSITIONS AND RELATED METHODS FOR NEURONAL NITRIC OXIDE SYNTHASE INHIBITION 审中-公开
标题翻译: 氨基吡啶二聚体化合物,组合物和相关方法用于神经氧化氮合酶抑制公开(公告)号:WO2010093787A3
公开(公告)日:2011-03-31
申请号:PCT/US2010023890
申请日:2010-02-11
发明人: SILVERMAN RICHARD B , XUE FENGTIAN
IPC分类号: A61K31/444 , A61P39/06 , C07D403/10 , C07D403/12 , C07D403/14
CPC分类号: C07D401/10 , C07D401/14
摘要: Nitric oxide synthase (NOS) inhibitor compounds comprising bi-terminal aromatic ring moieties, and related methods of NOS inhibition.
摘要翻译: 包含双末端芳环部分的一氧化氮合酶(NOS)抑制剂化合物和NOS抑制的相关方法。
-
公开(公告)号:WO2008108834A3
公开(公告)日:2008-12-04
申请号:PCT/US2007023644
申请日:2007-11-09
发明人: SILVERMAN RICHARD B , KUDOH TAKASHI
IPC分类号: A01N57/00 , C01G99/00 , A61K31/335 , A61K31/665
CPC分类号: C07F9/098 , C07C59/11 , C07C59/44 , C07D319/12
摘要: Compounds and related methods as can be used for selective mevalonate pathway inhibitors.
摘要翻译: 可用于选择性甲羟戊酸途径抑制剂的化合物和相关方法。
-
5.HETEROAROMATIC SELECTIVE INHIBITORS OF NEURONAL NITRIC OXIDE SYNTHASE 审中-公开
标题翻译: 神经元型一氧化氮合酶的异位选择性抑制剂公开(公告)号:WO2005026111A3
公开(公告)日:2005-09-15
申请号:PCT/US2004029080
申请日:2004-09-08
发明人: SILVERMAN RICHARD B , JI HAITAO
IPC分类号: A61K31/454 , A61K31/495 , A61K31/496 , A61K31/5377 , A61K31/541 , A61K31/55 , C07D20060101 , C07D413/02 , C07D417/02
CPC分类号: A61K31/55 , C07D401/06 , C07D401/14 , C07D417/06
摘要: Compounds inhibiting neuronal nitric oxide synthase (nNOS) for potential treatment in neurodegenerative diseases, such as stroke, Alzheimer's disease, Parkinson's disease, Huntington's disease, such compounds of a formula.
摘要翻译: 抑制神经元一氧化氮合酶(nNOS)化合物用于神经退行性疾病如中风,阿尔茨海默氏病,帕金森氏病,亨廷顿舞蹈病等潜在治疗的化合物如式
-
公开(公告)号:WO03000198A3
公开(公告)日:2003-03-06
申请号:PCT/US0220065
申请日:2002-06-24
申请人: UNIV NORTHWESTERN
IPC分类号: A61K38/00 , C07C281/16 , C07D207/16 , C07D213/38 , C07K5/065 , C07D207/04 , A61K31/16 , A61K31/40 , C07C233/05
CPC分类号: C07D213/38 , A61K38/00 , C07C281/16 , C07D207/16 , C07K5/06078
摘要: Peptidomimetic compositions for selective inhibition of neuronal nitric oxide synthase.
摘要翻译: 用于选择性抑制神经元一氧化氮合酶的拟肽组合物。
-
7.SPECIFIC NNOS INHIBITORS FOR THE THERAPY AND PREVENTION OF HUMAN MELANOMA 审中-公开
标题翻译: 特定的NNOS抑制剂治疗和预防人类血清公开(公告)号:WO2012097121A9
公开(公告)日:2012-10-04
申请号:PCT/US2012021030
申请日:2012-01-12
申请人: UNIV NORTHWESTERN , YANG SUN , MEYSKENS FRANK L , SILVERMAN RICHARD B , JI HAITAO , XUE FENGTIAN , POULOS THOMAS L
发明人: YANG SUN , MEYSKENS FRANK L , SILVERMAN RICHARD B , JI HAITAO , XUE FENGTIAN , POULOS THOMAS L
IPC分类号: C07D401/08 , A61K31/4439 , A61P35/00
CPC分类号: C07D401/06 , A61K31/4439
-
8.CHIRAL PYRROLIDINE CORE COMPOUNDS EN ROUTE TO INHIBITORS OF NITRIC OXIDE SYNTHASE 审中-公开
标题翻译: CHIRAL PYRROLIDINE CORE COMPOUNDS EN ROUTE TO NIVIC OXIDE SYNTHASE公开(公告)号:WO2010132873A2
公开(公告)日:2010-11-18
申请号:PCT/US2010035082
申请日:2010-05-17
发明人: XUE FENGTIAN , SILVERMAN RICHARD B
IPC分类号: C07D401/06 , A61K31/4439 , A61P25/28 , C07D401/04
CPC分类号: C07D401/06 , C07D401/04 , C07D401/14 , C07D405/14 , C07F7/10
摘要: Diastereomeric pyrrolidine compounds and methods of preparation, as can be used en route to the preparation of a range of nitric oxide synthase inhibitors.
摘要翻译: 非对映异构吡咯烷化合物和制备方法,可以用于制备一系列一氧化氮合酶抑制剂。
-
公开(公告)号:WO2008036294A3
公开(公告)日:2009-05-07
申请号:PCT/US2007020261
申请日:2007-09-19
发明人: SILVERMAN RICHARD B , JI HAITAO , TAN SIDHARTHA , DERRICK MATTHEW
IPC分类号: A61K31/555
CPC分类号: A61K31/4439
摘要: The present invention relates to preventive therapies and treatments of motor deficit disorders. In particular, the present invention relates to compositions and methods for preventative therapy and treatment of motor deficit disorders, such as cerebral palsy, in fetuses and newborn infants using inhibitors to neuronal nitric oxide synthase (nNOS).
摘要翻译: 本发明涉及运动缺陷障碍的预防性治疗和治疗。 特别地,本发明涉及使用神经元一氧化氮合成酶(nNOS)抑制剂来预防性治疗和治疗运动缺陷障碍(例如脑瘫,胎儿和新生儿)的组合物和方法。
-
公开(公告)号:WO0049022A3
公开(公告)日:2001-11-15
申请号:PCT/US0004014
申请日:2000-02-16
申请人: UNIV NORTHWESTERN
发明人: LEE YOUNGHEE , SILVERMAN RICHARD B
IPC分类号: C07B61/00 , C07F7/08 , C08F4/06 , C08F4/40 , C08F4/42 , C07F7/02 , C07D231/00 , C07D305/00 , C07F7/10 , C08G77/06
CPC分类号: C07F7/0818 , C07B2200/11 , C07F7/0812 , C40B40/00 , Y10T428/2962 , Y10T428/2995
摘要: A compound of formula (I) and a resin-bound compound of formula (II): and their use in combinatorial chemistry and in the synthesis of compounds comprising at least one aromatic moiety is described, where R , R , R , R , R , R , R , L , P, Ar , and X are as herein defined.
摘要翻译: 描述了式(I)化合物和式(II)的树脂结合化合物:及其在组合化学中的用途和合成包含至少一个芳族部分的化合物,其中R 1,R 2, R 3,R 4,R 5,R 6,R 7,L 1,P,Ar 1和X如本文所定义。
-
-
-
-
-
-
-
-
-